These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 22195801)
21. The influence of spray-drying parameters on phase behavior, drug distribution, and in vitro release of injectable microspheres for sustained release. Meeus J; Lenaerts M; Scurr DJ; Amssoms K; Davies MC; Roberts CJ; Van Den Mooter G J Pharm Sci; 2015 Apr; 104(4):1451-60. PubMed ID: 25648704 [TBL] [Abstract][Full Text] [Related]
22. Protein bioactivity and polymer orientation is affected by stabilizer incorporation for double-walled microspheres. Kokai LE; Tan H; Jhunjhunwala S; Little SR; Frank JW; Marra KG J Control Release; 2010 Jan; 141(2):168-76. PubMed ID: 19751780 [TBL] [Abstract][Full Text] [Related]
23. Biodegradable polyesterurethanes with shape-memory properties for dexamethasone and aspirin controlled release. Feng Y; Zhang S; Wang H; Zhao H; Lu J; Guo J; Behl M; Lendlein A J Control Release; 2011 Nov; 152 Suppl 1():e21-3. PubMed ID: 22195859 [No Abstract] [Full Text] [Related]
24. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts. Porta GD; Campardelli R; Falco N; Reverchon E J Pharm Sci; 2011 Oct; 100(10):4357-67. PubMed ID: 21638283 [TBL] [Abstract][Full Text] [Related]
25. [Effect of preparation technique on in vitro release mechanism of huperzine A microspheres]. Fu XD; Gao YL; Ping QN Yao Xue Xue Bao; 2006 Jul; 41(7):589-94. PubMed ID: 17007348 [TBL] [Abstract][Full Text] [Related]
26. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Feng R; Zhang Z; Li Z; Huang G Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001 [TBL] [Abstract][Full Text] [Related]
27. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases. Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
29. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone. Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580 [TBL] [Abstract][Full Text] [Related]
30. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
31. Influence of formulation composition and process on the characteristics and in vitro release from PLGA-based sustained release injectables. Meeus J; Scurr DJ; Appeltans B; Amssoms K; Annaert P; Davies MC; Roberts CJ; Van den Mooter G Eur J Pharm Biopharm; 2015 Feb; 90():22-9. PubMed ID: 25448071 [TBL] [Abstract][Full Text] [Related]
32. [Preparation and properties of Talpha1 loaded injectable sustained release microspheres]. Zhu Y; Lu Y; Zhong YQ Yao Xue Xue Bao; 2007 Feb; 42(2):211-5. PubMed ID: 17518054 [TBL] [Abstract][Full Text] [Related]
33. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Joshi SA; Chavhan SS; Sawant KK Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869 [TBL] [Abstract][Full Text] [Related]
34. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Jackson JK; Hung T; Letchford K; Burt HM Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895 [TBL] [Abstract][Full Text] [Related]
35. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257 [TBL] [Abstract][Full Text] [Related]
36. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres. Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924 [TBL] [Abstract][Full Text] [Related]
37. Interfacial Fast Release Layer in Monodisperse Poly (lactic-co-glycolic acid) Microspheres Accelerates the Drug Release. Wu J; Zhao X; Yeung KW; To MK Curr Drug Deliv; 2016; 13(5):720-9. PubMed ID: 26638974 [TBL] [Abstract][Full Text] [Related]
38. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment. Pagar KP; Vavia PR Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187 [TBL] [Abstract][Full Text] [Related]
39. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent. Young TJ; Johnston KP; Mishima K; Tanaka H J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502 [TBL] [Abstract][Full Text] [Related]
40. Modified emulsion solvent evaporation method for fabricating core-shell microspheres. Xiao CD; Shen XC; Tao L Int J Pharm; 2013 Aug; 452(1-2):227-32. PubMed ID: 23694803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]